CERTIFICATION

I, Mechael Kanovsky, Ph.D., certify the following:

1.       I have reviewed this annual report on Form 10-KSB of Amazon Biotech,
         Inc.;

2.       Based on my knowledge, this annual report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances under which
         such statements were made, not misleading with respect to the period
         covered by this annual report;

3.       Based on my knowledge, the financial statements, and other financial
         included in this annual report, fairly present in all material respects
         the financial condition, results of operations and cash flows of Amazon
         Biotech, Inc. as of, and for, the periods presented in this annual
         report;

4.       Amazon Biotech, Inc.'s other certifying officer and I are responsible
         for establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for Amazon
         Biotech, Inc. and we have done the following:

         a.       such disclosure controls and procedures, or caused disclosure
                  controls and procedures to be designed under our supervision,
                  to ensure that material information relating to Amazon
                  Biotech, Inc., including its consolidated subsidiaries, is
                  made known to us by others within those entities, particularly
                  during the period in which this annual report is being
                  prepared;

         b.       such internal control over financial reporting, or such
                  internal control over financial reporting to be designed under
                  our supervision, to provide reasonable assurance regarding the
                  reliability of financial reporting and the preparation of
                  financial statements for external purposes in accordance with
                  generally accepted accounting principles;

         c.       the effectiveness of Amazon Biotech, Inc.'s disclosure
                  controls and procedures and presented in this annual report
                  our conclusions about the effectiveness of the disclosure
                  controls and procedures, as of the end of the period covered
                  by this report based on such evaluation; and

         d.       in this annual report any change in Amazon Biotech, Inc.'s
                  internal control over financial reporting that occurred during
                  Amazon Biotech, Inc.'s fourth fiscal quarter that has
                  materially affected, or is reasonably likely to materially
                  affect, Amazon Biotech, Inc.'s internal control over financial
                  reporting; and

5.       Amazon Biotech, Inc.'s other certifying officer and I have disclosed,
         based on our most recent evaluation of internal control over financial
         reporting, to Amazon Biotech, Inc.'s auditors and the audit committee
         of the Amazon Biotech, Inc.'s board of directors:


<PAGE>

         a.       all significant deficiencies and material weaknesses in the
                  design or operation of internal control over financial
                  reporting which are reasonably likely to adversely affect
                  Amazon Biotech, Inc.'s ability to record, process, summarize
                  and report financial information; and

         b.       any fraud, whether or not material, that involves management
                  or other employees who have a significant role in Amazon
                  Biotech, Inc.'s internal control over financial reporting.


November 14, 2006                               /s/ Mechael Kanovsky, Ph.D.
                                                --------------------------------
                                                Mechael Kanovsky, Ph.D.
                                                President
                                                (Principal Executive Officer)